Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 3OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29Rectal Neoplasms 20Colonic Neoplasms 20Head and Neck Neoplasms 14Stomach Neoplasms 12Squamous Cell Carcinoma of Head and Neck 12Breast Neoplasms 11Esophageal Neoplasms 9Adenocarcinoma Of Esophagus 9Pancreatic Neoplasms 8Anus Neoplasms 8Anal Canal Carcinoma 6Urinary Bladder Neoplasms 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Squamous Intraepithelial Lesions 2Hepatoblastoma 2HIV Infections 2Carcinoma, Hepatocellular 2Tongue Neoplasms 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Radiation Injuries 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1

Interventions

PEGPH20 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Metastatic Pancreatic Adenocarcinoma × Fluorouracil × Clear all
NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed
126 enrolled 19 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡